Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001185185-19-001544
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-11-08 13:38:28
Reporting Period:
2019-11-06
Accepted Time:
2019-11-08 13:38:28
Original Submission Date:
2019-11-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1530766 Biosig Technologies Inc. BSGM () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261041 Steve Chaussy C/o Biosig Technologies, Inc.
54 Wilton Road, 2Nd Floor
Westport CT 06880
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2019-11-06 500 $6.66 596,330 No 4 P Direct
Common Stock, $0.001 Par Value Per Share Acquisiton 2019-11-06 500 $6.72 596,830 No 4 P Direct
Common Stock, $0.001 Par Value Per Share Acquisiton 2019-11-06 1,000 $6.88 597,830 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. These shares were erroneously reported in the original Form 4 as Awards (A). This amendment is filed to correct the transaction code to reflect that these shares were purchased (P) on the open market.